| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 01/28/2003 | US6511990 Class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof |
| 01/28/2003 | CA2417385A1 Substituted aryl ketones and their use as herbicides |
| 01/24/2003 | WO2002016308A1 Phenyl- and phenylalkyl-substituted ethanolamines and ethylenediamines |
| 01/23/2003 | WO2003006628A2 Nad synthetase inhibitors and uses thereof |
| 01/23/2003 | WO2003006443A2 2- 4-(naphtalin-2-yl)-thiazol-2-ylaminocarbonyl benzoic acid and 2- 4-(naphtalin-2-yl)-pyrimidin-2-ylaminocarbonyl benzoic acid and additional compounds serving as telomerase inhibitors for use in tumor therapy |
| 01/23/2003 | WO2003006437A1 Imidazole derivatives as adenosine deaminase inhibitors |
| 01/23/2003 | WO2003006436A1 Novel azole or triazole derivatives, method for preparing same and use thereof as fungicides |
| 01/23/2003 | WO2003006435A1 Process for oxidation of alcohols |
| 01/23/2003 | WO2003006423A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 01/23/2003 | WO2003006013A1 Diaminediols for the treatment of alzheimer's disease |
| 01/23/2003 | WO2003006012A1 Compounds and methods for the inhibition of trypanosoma cruz i |
| 01/23/2003 | WO2001051472A9 New imidazole derivatives |
| 01/23/2003 | US20030018080 N-methoxymethyl-5,5-diphenylbarbituric acid |
| 01/23/2003 | US20030018070 Bisaryl compound and medicament for cancer treatment comprising the same |
| 01/23/2003 | US20030018062 Deacetylase inhibitors |
| 01/23/2003 | US20030018034 Piperazine compounds and medicinal use thereof |
| 01/23/2003 | US20030018025 Psychological disorders, antidepressants, Parkinson's disease |
| 01/23/2003 | US20030018013 Cardiovascular disorders; antilipemic agents; Alzheimer's disease |
| 01/23/2003 | US20030017964 Administration of agents via the PEPT-2 transporter |
| 01/23/2003 | CA2453503A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 01/23/2003 | CA2453444A1 Diaminediols for the treatment of alzheimer's disease |
| 01/23/2003 | CA2453396A1 Compounds and methods for the inhibition of trypanosoma cruzi |
| 01/22/2003 | WO2002010131A1 Pyrrole derivatives |
| 01/22/2003 | EP1276743A1 Ion liquids derived from lewis acid based on titanium, niobium, tantalum, tin or antimony, and uses thereof |
| 01/22/2003 | EP1276726A2 Substituted phenyl farnesyltransferase inhibitors |
| 01/22/2003 | EP1276725A2 5-substituted tetralones as inhibitors of ras farnesyl transferase |
| 01/22/2003 | EP1276724A2 Dihydro-2h-naphthalene-1-one inhibitors of ras farnesyl transferase |
| 01/22/2003 | EP1276712A2 2,6-diamino-6-methyl-heptanoic acid and derivatives, process for the preparation thereof and use thereof |
| 01/22/2003 | EP0898562B1 Hydroxamic acid derivatives for use with the treatment of diseases related to connective tissue degradation |
| 01/22/2003 | CN1392876A Combretastatin A-4 phosphate prodrug, mono-and di-organic amine salt, mono-and di-amino acids salts, and mono-and di-amino acid ester salt |
| 01/22/2003 | CN1392874A Cyclic amidine compounds |
| 01/22/2003 | CN1392142A Process for synthesizing (imidazole-1-radical) acetic acid derivative |
| 01/22/2003 | CN1392141A Process for coalescing and separating cyclohexane oxidation waste lye |
| 01/22/2003 | CN1099407C Novel amino acid derivatives with improved multi-drug resistance activity |
| 01/22/2003 | CA2416946A1 Pyrrole derivatives |
| 01/21/2003 | US6509494 Distillation mixture of dicyclopentenyl esters |
| 01/21/2003 | US6509366 Substituted imidazoles as selective modulators of Bradykinin B2 receptors |
| 01/21/2003 | US6509363 P38 is a mitogen-activated protein kinase; pyrrole, oxazole, thiazole, and imidazole derivatives |
| 01/21/2003 | US6508954 1,3-dibromo-5,5-dimethylhydantoin of enhanced properties |
| 01/21/2003 | CA2078106C Treatment of central nervous system disorders with imidazole angiotensin-ii receptor antagonists |
| 01/17/2003 | WO2002006269A1 Cyclic amino acid derivatives |
| 01/17/2003 | CA2415964A1 Cyclic amino acid derivatives |
| 01/16/2003 | WO2003005025A1 Methods for identifying compounds modulating the activity of ppar-gamma |
| 01/16/2003 | WO2003004512A1 Activators for oligonucleotide synthesis |
| 01/16/2003 | WO2003004472A1 Arylamines for the treatment of conditions associated with gsk-3 |
| 01/16/2003 | WO2003004464A2 Heterocyclic amide derivatives and the use thereof as pesticides |
| 01/16/2003 | WO2003004458A1 New compounds |
| 01/16/2003 | WO2003004020A1 Heteroaryl carboxylic acid amides, the production thereof and the use of the same as inhibitors of the microsomal triglyceride transfer protein (mtp) |
| 01/16/2003 | WO2002070467B1 Derivatives of diphenylurea, diphenyloxalic acid diamide and diphenylsulfuric acid diamide and their use as medicaments |
| 01/16/2003 | WO2002050062A3 Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors |
| 01/16/2003 | US20030013892 Production of chirally pure alpha-amino acids and N-sulfonyl alpha-amino acids |
| 01/16/2003 | US20030013891 Process for the preparation of N,N'-carbonyldiazoles and azolide salts |
| 01/16/2003 | US20030013847 Pyruvate derivatives |
| 01/16/2003 | US20030013846 Cytoprotective agents |
| 01/16/2003 | US20030013751 Viricides; enzyme inhibitors |
| 01/16/2003 | US20030013725 Amino acid derivatives |
| 01/16/2003 | US20030013721 Antiinflammatory agents; immunology; cardiovascular disorders; rheumatic disorders |
| 01/16/2003 | US20030013706 Autoimmune disease; antiinflammatory agents |
| 01/16/2003 | US20030013704 Adamantane derivatives |
| 01/16/2003 | US20030013657 Reducing oxidation stresses; central nervous system disorders; antiinflammatory agents |
| 01/16/2003 | US20030013656 Reducing oxidation stresses; central nervous system disorders; antiinflammatory agents |
| 01/16/2003 | CA2452686A1 Arylamines for the treatment of conditions associated with gsk-3 |
| 01/15/2003 | EP0974584B1 Fused ring compounds, process for producing the same and use thereof |
| 01/15/2003 | EP0729468B1 Non-peptide tachykinin receptor antagonists |
| 01/15/2003 | CN1391565A Benzophenones as inhibitors of reverse transcriptase |
| 01/15/2003 | CN1391559A Procedure for producing formyl imidazoles |
| 01/15/2003 | CN1391474A 5-membered heterocycle derivatives, production thereof and use as medicaments |
| 01/15/2003 | CN1391469A Npyy5拮抗剂 Npyy5 antagonist |
| 01/15/2003 | CN1390836A Optical antimer of Saikexiaozuo and its preparing process and usage |
| 01/15/2003 | CN1098841C Novel amide derivatives and medicinal compositions thereof |
| 01/14/2003 | US6506936 N-substituted arylsulfonylamino hydroxamic acids useful as inhibitors of c-proteinase and for treating or preventing disorders related to unregulated collagen production |
| 01/14/2003 | US6506906 Preparation and use of bifunctional molecules having DNA sequence binding specificity |
| 01/14/2003 | US6506799 Treating or preventing a cardiovascular disease in a patient, comprising administering to a patient in need of such treatment or prevention a therapeutically effective amount of 6-(6-hydroxy-5,5-dimethylhexyloxy)-2,2-dimethyl-hexan-1-ol and |
| 01/14/2003 | US6506517 Surface modified carbonaceous materials |
| 01/09/2003 | WO2003002540A1 Cyclic diamine compound having five-membered cyclic group |
| 01/09/2003 | WO2003002519A1 Phenol derivatives and their use in medicaments |
| 01/09/2003 | WO2003002491A2 ENANTIOSELECTIVE TRANSFORMATION OF α, β-UNSATURATED ALDEHYDES USING CHIRAL ORGANIC CATALYSTS |
| 01/09/2003 | WO2003002122A1 Beta-hydroxyamine derivatives useful in treatment of alzheimer's disease |
| 01/09/2003 | WO2002083716A3 Type b botulism toxin inhibitors |
| 01/09/2003 | WO2001072728B1 Novel piperazine derivatives |
| 01/09/2003 | US20030009035 Heating alkyleneoxide and carbon dioxide and alkylamine or alkylamine compound and 1,3-dialkylurea to form 1,3-Dialkyl-2-imidazolidinones |
| 01/09/2003 | US20030008913 For controlling harmful insects, acarids and nematodes |
| 01/09/2003 | US20030008796 Composition and method for bleaching a substrate |
| 01/09/2003 | CA2452039A1 Beta-hydroxyamine derivatives useful in treatment of alzheimer's disease |
| 01/08/2003 | EP1273571A1 Nitrogenous compounds and antiviral drugs containing the same |
| 01/08/2003 | EP1272900A2 High speed photothermographic materials containing tellurium compounds and methods of using same |
| 01/08/2003 | EP0923560B1 Bridged and possibly methylolized 4,5-bis-di-hidroxy-imidazolidin-2-ones, process for their production and use thereof |
| 01/08/2003 | EP0889033B1 Alpha-substituted benzyl heterocyclic derivatives, intermediates for producing the same, and pesticides containing the same as active ingredient |
| 01/08/2003 | CN1390193A Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 01/08/2003 | CN1389458A P-methylsulfonyl phenylacrylate derivative and its prepn process and anti-inflammatory effect |
| 01/08/2003 | CN1098256C Substd. benzenesulfonamide derivatives as prodrugs of COX-2 inhibitors |
| 01/08/2003 | CN1098070C Guanylhydrazones for treating inflammatory conditions |
| 01/07/2003 | US6504047 2,6-diamino-6-methyl-heptanoic acid and derivatives, process for the preparation thereof and use thereof |
| 01/07/2003 | US6503935 Imidazoles and related compounds as α1A agonists |
| 01/07/2003 | US6503929 Nitrate salt of anti-ulcer medicine |
| 01/07/2003 | CA2075590C Hydantoin derivatives |
| 01/03/2003 | WO2003000662A2 Chiral preparation of a diastereomeric compound |
| 01/03/2003 | WO2002083656A3 5-membered heterocycles, preparation and use thereof as mao inhibitors and lipid peroxidation inhibitors, preparation thereof and use thereof as medicaments |
| 01/03/2003 | WO2002064577A3 Method for preparing compounds derived from thiazolidinedione, oxazolidinedione |
| 01/02/2003 | US20030004358 Treatment of peptic ulcers |